With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.145589-03-3,(R)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one,as a common compound, the synthetic route is as follows.
THE 3 (S)-ISOPROPYL-5 (S)-1(S)-AZIDO-3 (S)-ISOPROPYL-4-OXO-butyl-tetrahydrofuran-2-one used in step d) is prepared as follows: g) 2 (S), 7 (S) -Diisopropyl-oct-4-ene-dicarboxylic acid [bis (4 (S) -benzyl-oxazolidin-2-one)]-amide 48 ml of a 1.0 M solution of lithium hexamethyldisilazide in tetrahydrofuran are added dropwise, with stirring, AT-75C,] within a period of one hour, to a solution of 11.5 g of 4 (S)- benzyl-3-isovaleroyl-oxazolidin-2-one in 32 ml of tetrahydrofuran. The mixture is stirred further for 2 hours at- [75C] and for 20 minutes [AT-20C,] and there are then added thereto 10 ml of 1, 3-dimethyl-3,4, 5,6-TETRAHYDRO-2- (1H)-pyrimidone (DMPU) and, within a period of 45 minutes, a solution of 4.28 g of 1, 4-dibromo-2-butene in 10 ml of tetrahydrofuran. The reaction mixture is stirred for a further 15 hours AT-20C and is then brought to [0C] within a period of one hour; 10 ml of saturated ammonium chloride solution are then added thereto at- [20C] and, after 15 minutes, the mixture is brought to room temperature. The reaction mixture is then partitioned between dichloromethane and saturated sodium chloride solution/water=1 : 1. The organic phases are combined, dried over sodium sulfate and concentrated by evaporation, and the residue is purified by means of FC (hexane/ethyl acetate=4: 1), yielding the title compound: Rf (hexane/ethyl acetate=4: 1) =0.30 ; HPLC Rt =21.6 minutes; FAB-MS (M+H) [+] =575; m. p. [=110-111C.], 145589-03-3
As the paragraph descriping shows that 145589-03-3 is playing an increasingly important role.
Reference£º
Patent; ELAN PHARMACEUTICALS, INC.; WO2003/103653; (2003); A1;,
Oxazolidine – Wikipedia
Oxazolidine | C3H7NO – PubChem